Healthcare · NYSE/NASDAQ: ISRG
INTUITIVE SURGICAL INC
Medical Instruments & Supplies
Market Cap $147.53B
Verdict: Exceptional
Quality Scores
Multi-Bagger
88/100
Compounder Quality
96/100
Management Credibility
95/100
Governance
98/100
Cash Flow Quality
97/100
AI Summary
Intuitive Surgical (ISRG) demonstrates exceptional dominance in the robotic-assisted surgery market, maintaining a near-monopoly position with its Da Vinci and Ion platforms. The company's financial profile is characterized by a high-margin recurring revenue model, where instruments and services now outweigh system sales. Over the last decade, ISRG has scaled its revenue from $1.05B to over $10B, maintaining a pristine debt-free balance sheet. The business model benefits from massive network effects and high switching costs as surgeon training becomes standardized on their hardware. Recent…
Top Opportunities
- Zero long-term debt and clean balance sheet
- Massive installed base of over 8,000 systems
- Recurring revenue (instruments/services) > 75% of total
Top Risks
- Heavy reliance on elective surgery volumes
- Intensifying competition from Medtronic and J&J
- High concentration in specialized robotic surgery
Latest report: Read the annual report summary →
Unlock the full report
Full sections, financial charts, AI chat and PDF export are available with Premium.